DORM Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment SAH Q1 2026 Earnings EPS Surpasses Estimates by 1487 Signaling Operational Strength DIS Q1 2026 Earnings Beat on EPS Amid Mixed Segment Performance ALMS Q1 2026 Earnings EPS Beat Partially Offsets Investor Concerns Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline MCHP Q1 2026 Earnings EPS Beat Fails to Lift Stock as Revenue Concerns Linger